A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research
